Suchergebnisse - "Min, Gi-June"

PubPharm (100)

61

Safety and efficacy of arsenic trioxide and all-trans retinoic acid therapy in acute promyelocytic leukemia patients with a high risk for early death

enthalten in: Annals of hematology | 2020

von Min, G. | Cho, B. | Park, S. | +14

62

Safety and efficacy of arsenic trioxide and all-trans retinoic acid therapy in acute promyelocytic leukemia patients with a high risk for early death

enthalten in: Annals of hematology | 2020

von Min, G. | Cho, B. | Park, S. | +14

63

Safety and efficacy of arsenic trioxide and all-trans retinoic acid therapy in acute promyelocytic leukemia patients with a high risk for early death

enthalten in: Annals of hematology | 2020

von Min, G. | Cho, B. | Park, S. | +14

64

Prognostic impact of interim positron emission tomography in mantle cell lymphoma patients treated with frontline R-CHOP

enthalten in: British journal of haematology | 2020

von Jeon, Y. | O, J. | Park, K. | +6

CommentIn: Br J Haematol. 2020 May;189(4):600-602. - PMID 31997341

65

Poor prognosis in patients with diffuse large B cell lymphomas with bone marrow involvement possessing chromosomal abnormalities, despite aggressive treatment

enthalten in: Annals of hematology | 2020

von Min, G. | Jeon, Y. | Park, S. | +13

66

Poor prognosis in patients with diffuse large B cell lymphomas with bone marrow involvement possessing chromosomal abnormalities, despite aggressive treatment

enthalten in: Annals of hematology | 2020

von Min, G. | Jeon, Y. | Park, S. | +13

67

Poor prognosis in patients with diffuse large B cell lymphomas with bone marrow involvement possessing chromosomal abnormalities, despite aggressive treatment

enthalten in: Annals of hematology | 2020

von Min, G. | Jeon, Y. | Park, S. | +13

68

Poor prognosis in patients with diffuse large B cell lymphomas with bone marrow involvement possessing chromosomal abnormalities, despite aggressive treatment

enthalten in: Annals of hematology | 2020

von Min, G. | Jeon, Y. | Park, S. | +13

69

Experiences of allogeneic hematopoietic cell transplantation following non-myeloablative conditioning regimen in severely comorbid patients with myelofibrosis : case series with a patient presenting with extensive extramedullary hematopoiesis

enthalten in: Therapeutic advances in hematology | 2020

von Yoon, J. | Park, S. | Min, G. | +10

70

HLA-mismatched donor and high ferritin level showed poor clinical outcomes after allogeneic hematopoietic cell transplantation in patients with advanced myelofibrosis

enthalten in: Therapeutic advances in hematology | 2020

von Yoon, J. | Min, G. | Park, S. | +10